Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

278
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
278
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

240
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
240

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Predicted T-Cell and B-Cell Epitopes of NIS: Where Do Sjögren's Syndrome and Hashimoto's Thyroiditis Converge?

International journal of molecular sciences·2026
Same author

Unlocking the Power of the Mediterranean Diet: Two in One-Dual Benefits for Rheumatic and Thyroid Autoimmune Diseases.

Nutrients·2025
Same author

The Effect of Therapeutic Exercise and Local Cryotherapy on Lower Limb Enthesitis in Non-Radiographic Axial Spondyloarthritis: A Case Report.

Journal of personalized medicine·2024
Same author

Metaproteomics reveals diet-induced changes in gut microbiome function according to Crohn's disease location.

Microbiome·2024
Same author

Pediatric migraine is characterized by traits of ecological and metabolic dysbiosis and inflammation.

The journal of headache and pain·2024
Same author

Sequence Alignment between <i>TRIM33</i> Gene and Human Noncoding RNAs: A Potential Explanation for Paraneoplastic Dermatomyositis.

Journal of personalized medicine·2024

相关实验视频

Updated: Sep 18, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

545

贝卡林作为治疗系统性硬化症的潜在候选者.

Giada Cimino1, Federica Rapisarda2, Rossella Talotta3

  • 1Nursing Degree School, University of Messina, Messina, Italy.

Inflammopharmacology
|June 23, 2025
PubMed
概括

拜卡林是一种天然化合物,通过解决其核心问题:免疫功能障碍,血管病变和纤维化,显示出治疗系统性硬化症 (SSc) 的潜力. 需要进一步的临床研究来证实它在SSc患者中的有效性和安全性.

关键词:
替代医学是一种医学.这是一种自身免疫力.贝卡林和贝卡林是什么意思内皮质功能障碍 内皮质功能障碍纤维化 纤维化 纤维化系统性硬化症 系统性硬化症

更多相关视频

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

1.2K
Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
08:09

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

8.2K

相关实验视频

Last Updated: Sep 18, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

545
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

1.2K
Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
08:09

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

8.2K

科学领域:

  • 免疫学 免疫学 免疫学
  • 类风湿病学 类风湿病学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 系统性硬化症 (SSc) 是一种复杂的结缔组织疾病,涉及免疫细胞激活,内皮功能障碍和纤维化.
  • 目前的SSc治疗是有限的,因为不完全理解病原体.
  • 贝卡林是来自Scutellaria baicalensis的黄类化合物,在各种临床前疾病模型中已经证明了它的有效性.

研究的目的:

  • 审查贝卡林在管理SSc.中的潜力.
  • 探索贝卡林对SSc关键病理特征的机制:血管病变,免疫功能障碍和纤维化.

主要方法:

  • 现有文献的叙述性审查.
  • 对贝卡林已知药理作用的分析.
  • 对SSc病原性相关性的评估.

主要成果:

  • 拜卡林表现出多种机制,包括TLR4对抗性,TGF-β/Smad3通路抑制和抗氧化作用.
  • 这些特性与抵消SSc的致病性三元组相一致.
  • 临床前数据表明,在相关条件下,有潜在的益处.

结论:

  • 贝卡林基于其多方面的药理学特征,为SSc提供了一个有前途的治疗候选药物.
  • 它在治疗血管病变,免疫功能障碍和纤维化方面的潜力需要进一步研究.
  • 临床试验对于确定贝卡林在SSc患者中的有效性和安全性至关重要.